Recent Updates
Recently added Catalysts
VTRS Positive Sentiment Score: 60/100

Viatris to Release Third Quarter 2023 Financial Results on November 7, 2023 Viatris Inc. (NASDAQ: VTRS) plans to release its third quarter 2023 financial results on Tuesday, November 7 after the close of the U.S. financial...

Key Takeaway: Viatris Inc. (NASDAQ: VTRS) has announced it will release its third quarter 2023 financial results on November 7, following the close of U.S. financial markets. The company will host a webcast at 5:00 p.m. ET that day, where its CEO, President, and CFO will discuss the results. This engagement reflects the company's commitment to transparency and investor interaction.

Market Sentiment Analysis

POSITIVE FACTORS

  • Viatris is set to release its Q3 2023 financial results, indicating company transparency.
  • The announcement demonstrates Viatris's proactive approach in engaging with investors and the public.
  • The webcast allows for direct communication with stakeholders, showcasing corporate openness.

Full Press Release Details

PITTSBURGH , Oct. 10, 2023 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS ) plans to release its third quarter 2023 financial results on Tuesday, November 7 after the close of the U.S. financial markets. Chief Executive Officer Scott A. Smith , President Rajiv Malik , and Chief Financial Officer Sanjeev Narula also will host a webcast at 5:00 p.m. ET on November 7 to discuss the results.
Investors and the general public are invited to listen to a live webcast of the call at investor.viatris.com or by calling 800.274.8461 or 203.518.9783 for international callers (Conference ID: VTRSQ323). A replay of the webcast also will be available on the website.
About Viatris Viatris Inc. ( NASDAQ : VTRS ) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale. In 2022 alone, we supplied high-quality medicines to approximately 1 billion patients around the world. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris . We have the ability to touch all of life's moments, from birth to end of life, acute conditions to chronic diseases. We are headquartered in the U.S., with global centers in Pittsburgh , Shanghai and Hyderabad , India. Learn more at viatris.com and investor.viatris.com , and connect with us on Twitter , LinkedIn , Instagram and YouTube .
SOURCE Viatris Inc.

21 %

About Viatris Inc.

Ticker Symbol: VTRS
Exchange: NASDAQ
Mission: Empower people worldwide to live healthier at every stage of life
Patient Reach: ~1 billion patients annually
Global Centers: Pittsburgh, Shanghai, Hyderabad

Frequently Asked Questions

When will Viatris release its Q3 2023 financial results?

Viatris will release its Q3 2023 financial results on November 7.

Who will host the webcast for Viatris' financial results?

CEO Scott A. Smith, President Rajiv Malik, and CFO Sanjeev Narula will host it.

How can the public access the Viatris webcast?

The webcast can be accessed at investor.viatris.com or by phone.

What is Viatris' mission?

Viatris aims to empower people worldwide to live healthier lives at every stage.

Where is Viatris headquartered?

Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai, and Hyderabad.

Last updated: Oct 10, 2023